Bisphenol-A: the Dangers of Prenatal BPA Exposure

Compelling need for a precautionary approach to avoid human exposure to BPA during prenatal development

The Science Indicates the Need for a Precautionary Approach

Disrupted Development: The Dangers of Prenatal BPA Exposure
The 2013 Breast Cancer Fund Report

The combination of human-association studies and experimental studies in animals provide compelling evidence that low-dose, prenatal exposures to Bisphenol-A (BPA) can lead to a wide range of later-life health concerns. These health effects encompass a wide range of adverse outcomes, including altered brain development, behavior changes, metabolic changes, adverse reproductive outcomes, and changes in breast and prostate development linked to later-life cancer risk in these organs. This collection of health effects is biologically plausible,138 given BPA’s capacity to mimic estrogen, and to therefore disrupt the delicate process of fetal development that is orchestrated by hormones. While inter-species differences may exist in the absorption and metabolism of BPA, the weight of the compiled evidence suggests that viable routes of exposure to active BPA exist for humans. This indicates a compelling need for a precautionary approach to avoid human exposure to BPA during prenatal development.

A 2013 Report by the Breast Cancer Fund

  • Protecting Us from BPA = Protecting the Next Generation
  • A Brief History of BPA
  • Prenatal Exposure to BPA: Exploring the Science
  • DES: A Cautionary Tale
  • Health Effects of Prenatal BPA Exposure
  • Table 1. Prenatal BPA Exposure and Biological Effects in Animals
  • Table 2. Prenatal BPA Exposure and Health Associations in Humans
  • Solutions: Getting BPA out of Food Packaging
  • Alternatives to BPA
  • APPENDIX 1 – Maternal BPA Levels in Humans
  • APPENDIX 2 – Prenatal BPA Levels in Humans
  • APPENDIX 3 – Research Methods: Making Sense of Animal and Human Studies

Sources: Breast Cancer Fund’s report ” Disrupted Development: The Dangers of Prenatal BPA Exposure “, a comprehensive review of the scientific literature on prenatal BPA exposure, Sptember 2013.

More DES DiEthylStilbestrol Resources

Critical Periods of Breast Development, Chemical Exposures and Breast Cancer Risk

Animation video published by Breast Cancer Fund, 2013

This video was produced by Vassar College’s Environmental Risks and Breast Cancer project. It describes the critical periods of breast development and explains how exposures to toxic chemicals at susceptible stages can lead to increased risk for developing breast cancer later in life.

Bisphenol-A disrupts fetal Development

The Dangers of Prenatal BPA Exposure

BPA disrupts fetal development
BPA disrupts fetal development

The toxic chemical Bisphenol-A (BPA), found in most canned foods on our supermarket shelves, disrupts fetal development and sets the stage for later-life diseases, including breast cancer, according to the Breast Cancer Fund’s report ” Disrupted Development: The Dangers of Prenatal BPA Exposure “, a comprehensive review of the scientific literature on prenatal BPA exposure, just-released.

Read BPA disrupts fetal Development, by Margie Kelly, Breast Cancer Fund Communications strategist, 10 September 2013.

Related posts:

Find out more about BPA – Endocrine disruptors – phthalates

DiEthylStilbestrol DES: a Cautionary Tale…

Disrupted Development: The Dangers of Prenatal Estrogen Exposure

Read:
DES: a Cautionary Tale

Abstract:

The drug diethylstilbestrol (DES) provides a striking andtragic example of the effects of prenatal exposures to chemicals that disrupt our hormones. DES was initially synthesized by a research team in London that had been searching for compounds that could be used for estrogen replacement during menopause, then referred to as deficiency disease. DES was approved by the FDA in 1941 to prevent miscarriages. It was prescribed to pregnant women for this purpose until 1971.

Early systematic studies failed to find evidence that DES was effective at preventing miscarriages but it continued to be prescribed to pregnant women. The wide use of DES created an accidental experiment that led to 5 to 10 million pregnant women – and the children born from those pregnancies – being exposed to this synthetic estrogen.

From 1966 to 1969, doctors at the Vincent Memorial Hospital in Boston noted a pattern of rare vaginal cancers in young women. These cancers were rare even in women over 50, and the hospital had never seen a single case of that specific type of cancer in younger women prior to 1966. The doctors conducted a study to determine similarities among the women, and found that the common thread was their mothers’ use of DES during their pregnancies. The doctors published a paper reporting
their findings in the New England Journal of Medicine in 1971, after which DES prescriptions were halted.

Since 1971, further research has linked prenatal DES exposure to a nearly two-fold increase in breast cancer among women over 40, and even higher rates among women over 50. Women who were presumed to have the highest exposures to DES (estimated based upon how much their vaginal cells were altered) had a higher risk of breast cancer.

The story of DES provides a cautionary tale about prenatal exposures to chemicals that can mimic the body’s own hormones. BPA is one such compound – In fact, BPA was even considered as an estrogen replacement by the same London laboratory that first created DES. As the DES story underscores, it can take decades to recognize the long-term health effects of early exposures to hormone-disrupting compounds in the general population, making it even more critical that we act on early warnings of harm. ”

Sources: Breast Cancer Fund’s report ” Disrupted Development: The Dangers of Prenatal BPA Exposure “, a comprehensive review of the scientific literature on prenatal BPA exposure, just-released.

More DES DiEthylStilbestrol Resources